CJC-1295 No DAC and Tesamorelin Safety Panels Published

Two growth-hormone-axis research peptides now have documentation on the COAs page.

CJC-1295 no DAC, 10 mg

The two-page Vanguard Laboratory report lists HPLC-UV/VIS purity of 99.46% ± 0.18% and an assay of 9.11 mg. Page two shows arsenic, cadmium, lead and mercury as not detected by ICP-MS, an endotoxin pass and a sterility result of no growth detected under USP <71>.

Tesamorelin, 10 mg

We have published the report’s safety page: heavy metals not detected, endotoxin below 5.00 EU/mg (pass) and no growth in the sterility test. The purity page is not online yet, and the COAs page says so. If you need the full batch documentation, ask through the contact form.

How to use these

Safety panels complement purity: they test for contaminants an HPLC trace would not show. Our education guide Growth Hormone Secretagogue Research explains where each compound fits, and How to Read a Peptide Certificate of Analysis explains the panels.

Browse Individual Products or the CJC no DAC/Ipamorelin blend.

Why safety panels matter

HPLC shows how much of a sample is the target peptide, but it does not look for trace metals, bacterial endotoxins or living organisms. Those need their own tests, and for a compound that will be dissolved and used in sensitive in vitro systems, an endotoxin result in particular can decide whether an experiment is usable at all. Seeing all three panels next to the purity result gives a more complete picture of a vial.

For laboratory research use only. Not for human or veterinary use. Not evaluated by the FDA.